TITLE

High-level expression of periostin is closely related to metastatic potential and poor prognosis of hepatocellular carcinoma

AUTHOR(S)
Lv, Yang; Wang, Wei; Jia, Wei-Dong; Sun, Qi-Kai; Li, Jian-Sheng; Ma, Jin-Liang; Liu, Wen-Bin; Zhou, Hang-Cheng; Ge, Yong-Sheng; Yu, Ji-Hai; Xia, Hong-Hai; Xu, Ge-Liang
PUB. DATE
March 2013
SOURCE
Medical Oncology;Mar2013, Vol. 30 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Periostin (PN) is a kind of secreted glycoprotein, which is closely related to the metastatic potential and prognosis of many kinds of tumors in recent studies. However, the expression level of PN in hepatocellular carcinoma (HCC) and its correlation with tumor angiogenesis and prognosis remain unclear. Here Immunohistochemistry assay was used to determine the expression of PN in HCC and corresponding adjacent tissues from 71 patients. VEGF and CD34 were only examined in HCC tissues of patients mentioned above. Immunohistochemically, the expression of PN in HCC was judged to be positive in 73.2 % (52/71) compared with 19.7 % (14/71) in corresponding adjacent tissues, and it was associated with tumor nodules ( P = 0.070), microvascular invasion ( P = 0.013), Edmondson grade ( P = 0.003), tumor capsula ( P = 0.038) and TNM stage ( P = 0.000); besides, tumors with PN-positive group expressed higher VEGF (82.7 vs. 26.3 %, χ = 20.195, P = 0.000) and had higher MVD (80.5 ± 36.5 vs. 24.0 ± 19.9, t = −6.395, P = 0.000) than those in PN-negative group. Kaplan-Meier method was used for survival analysis, and Cox regression model was performed for multivariate survival analysis. In particular, the expression of PN was found to be an independent factor for predicting overall and disease-free survival of HCC. It is possible that the expression level of PN in HCC is associated with tumor metastatic potential and angiogenesis. Its abnormal expression could be a predictive factor to anticipate HCC patient's prognosis after surgery.
ACCESSION #
85859830

 

Related Articles

  • KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma. Lei Shi; Wenfa Zhang; Fagui Zou; Lihua Mei; Gang Wu; Yong Teng // BMC Cancer;10/21/2016, Vol. 16, p1 

    Background: Hepatocellular carcinoma (HCC) has very high prevalence and associated-mortality. However, targeted therapies that are currently used in clinical practice for HCC have certain limitations, in part because of the lack of reliable and clinically applicable biomarkers that can be used...

  • MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis. Xiao-Ying Huang; Jin-Guang Yao; Hong-Dong Huang; Chao Wang; Yun Ma; Qiang Xia; Xi-Dai Long // Gastroenterology Research & Practice;2013, p1 

    MicroRNA-429 (miR-429) may modify the development and progression of cancers; however, the role of this microRNA in the hepatocellular carcinoma (HCC) has not been well elaborated. Here, we tested miR-429 expression in 138 pathology-diagnosed HCC cases and SMMC-7721 cells. We found that miR-429...

  • Prognostic Significance of Glycoprotein 96 in Human Hepatocellular Carcinoma. Xiaoping WANG; Huanping LIN; Bing XU; Kepei ZHANG; Jinggang FANG; Yixin YANG // Advanced Materials Research;7/24/2014, Vol. 989-994, p1037 

    Glycoprotein 96(gp96) is highly expressed in cancer tissues. Recent studies indicate the possible roles of gp96 in the development and progression of hepatocellular carcinomas but detailed information is still ambiguous. The aim of the study is to investigate the correlation between...

  • Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. Kaposi-Novak, Pal; Lee, Ju-Seog; Gòmez-Quiroz, Luis; Coulouarn, Cédric; Factor, Valentina M.; Thorgeirsson, Snorri S.; Gòmez-Quiroz, Luis; Coulouarn, Cédric // Journal of Clinical Investigation;Jun2006, Vol. 116 Issue 6, p1582 

    Identification of specific gene expression signatures characteristic of oncogenic pathways is an important step toward molecular classification of human malignancies. Aberrant activation of the Met signaling pathway is frequently associated with tumor progression and metastasis. In this study,...

  • Reduced expression of DACT2 promotes hepatocellular carcinoma progression: involvement of methylation-mediated gene silencing. Sheng Gao; Zhe Yang; Zheng, Zhi-Yun; Jia Yao; Feng Zhang; Wu, Li-Ming; Xie, Hai-Yang; Lin zhou; Zheng, Shu-Sen // World Journal of Surgical Oncology;2013, Vol. 11 Issue 1, p1 

    Background: Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies in humans, and its prognosis is generally poor even after surgery. Many advances have been made to understand the pathogenesis of HCC; however, the molecular mechanisms that lead to hepatocarcinogenesis and...

  • STAT3 protein expression profile and its clinical significance in hepatocellular carcinoma. GOU Zepeiig; WANG Desheng; ZHOU Liang // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;jul2013, Vol. 29 Issue 7, p520 

    Objective To determine the protein expression profiles of STAT3 ad its activated form, p - STAT3, in hepatocellular carcinoma ( ??? ) and investigate the potential clinica significance. Methods The expressions of STAT3 ad p - STAT3 were detected in 90 ??? tissues ad patient - matched cancer -...

  • The role of DEK protein in hepatocellular carcinoma for progression and prognosis. Li-juan Lin; Li-tian Chen // Pakistan Journal of Medical Sciences;Jun2013, Vol. 29 Issue 3, p778 

    Objective: The study aim was to explore the role of DEK in tumor progression and prognostic of hepatocellular carcinoma (HCC). Methodology: DEK protein in 178 samples of HCC was evaluated by immunohistochemical method. Additionally, the correlation between DEK expression and the...

  • Down-regulated KLF17 expression is associated with tumor invasion and poor prognosis in hepatocellular carcinoma. Liu, Fu-Yao; Deng, Yue-Ling; Li, Yuan; Zeng, Dan; Zhou, Zhen-Zhen; Tian, De-An; Liu, Mei // Medical Oncology;Mar2013, Vol. 30 Issue 1, p1 

    Although the role of Krüppel-like factor 17 (KLF17) in regulating epithelial-mesenchymal transition (EMT) has been explored in breast cancer, its influence on primary hepatocellular carcinoma (HCC) remains unclear. This study aims to investigate the expression status of KLF17 in...

  • Over-expression of Na/H exchanger 1 and its clinicopathologic significance in hepatocellular carcinoma. Yang, Xuekang; Wang, Desheng; Dong, Wei; Song, Zhenshun; Dou, Kefeng // Medical Oncology;Dec2010, Vol. 27 Issue 4, p1109 

    The activation of Na/H exchanger 1 (NHE1) is involved in the formation of tumor cell pseudopodia, possibly resulting in their malignant potential. The clinicopathological significance of NHE1, however, is not yet well known in the case of hepatocellular carcinoma (HCC). In this study, we first...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics